Health at Scale's AI-driven system deployed by Personify Health proven to save money and address upstream source of inequities in care delivery
PROVIDENCE, R.I. and SAN JOSE, Calif., Sept. 19, 2024 /PRNewswire/ -- Fraud, waste, and abuse (FWA) has long been a challenging issue within the U.S. healthcare system, contributing to rising costs and compromised patient care. Today, researchers from Personify Health, Health at Scale, Massachusetts Institute of Technology, and University of Michigan announce a new peer-reviewed study on the reduction of FWA in healthcare insurance claims. Published in NEJM Catalyst Innovations in Care Delivery, the study highlights the successful deployment of AI-driven technology by Personify Health, the industry's first personalized health platform company, resulting in an $11.8 million reduction in paid claim amounts over an eight-month period.
Key study findings include:
- More than half of flagged claims reduced – 54% of the claims flagged for subsequent clinical review saw a reduction in paid amounts, leading to an average savings of $3,916 per flagged claim – totaling more than $11.8 million, a 1.2% reduction of the total spend of $981.3 million.
- Meaningful reductions seen at all dollar ranges – Noteworthy reductions were observed across different claim value ranges, including for healthcare services that are low-cost but high-volume:
- Claims over $50,000: 58% of these high-cost claims saw a decrease in paid amounts, with an average savings of $20,513 per claim.
- Claims $5,000 - $49,999: Between 56% - 68% of these claims experienced a reduction in paid amounts, resulting in an average savings range from $1,504 for lower dollar claims to $10,420 for higher dollar claims.
- Claims under $5,000: 42% of claims falling below $5,000 had a reduction in paid amounts, saving an average of $236 per claim.
- Specialties top the list for highest reductions – 10 service types are responsible for 56% of overall spend but accounted for 64% of all flagged claims. The greatest average reductions in paid amounts per flagged claim were observed for cardiovascular procedures ($10,332 average reduction), critical care services ($10,332), and musculoskeletal procedures ($9,604).
"The study spotlights the significant savings being left on the table by traditional methods for FWA identification based on rules and high-dollar thresholds," said Justin Tran, chief strategy officer at Personify Health. "Using AI to fight FWA has been a key investment for many for the past decade, but most models have only provided incremental improvements and have failed to perform sufficiently to transform processes. With real-time, AI-enabled FWA screening, we are unlocking substantial savings and operational improvements for healthcare stakeholders. We're now seeing the transformative potential of real-time AI solutions in combatting FWA and promoting cost-effective, patient-centered care delivery."
With estimated annual costs of medical waste in the U.S. amounting to more than a trillion dollars, the study underscores the critical need for innovative approaches to prevent overspending on unnecessary services and overpaid or mismanaged claims in the healthcare industry. Additionally, FWA analysis has typically focused on manual high-dollar claim review ($100,000 or more), leaving FWA in lower cost claims largely unchecked. Until now, no one has cracked the code for solving this problem before money gets spent.
Impact on Socially Vulnerable Populations
FWA disproportionately impacts vulnerable populations, perpetuating health disparities among these groups. The study highlights the role of AI in protecting underserved individuals from substandard and harmful healthcare practices. Researchers found that the AI-based FWA claim screening resulted in the most socially vulnerable members saving an average of $3,973 per claim, an 18% greater avoidance of inappropriate healthcare reimbursements.
"Addressing FWA can be a painful, time-consuming process when it occurs after payment has been made. But more than just the dollars spent, harm can occur through provider mistakes, bad behavior, and unnecessary care resulting in negative side effects or health complications," said Zeeshan Syed, lead study author and co-founder & CEO of Health at Scale. "Too often, inaccurate claims and inappropriate care go unnoticed – especially among vulnerable populations who have limited care options. By leveraging a more effective approach to FWA screening, we can protect vulnerable populations disproportionately impacted and help create a more equitable healthcare system."
To access the full study, "Reducing Fraud, Waste, and Abuse Through Real-Time AI-Based Screening: Prospective Results in Deployment," visit the October 2024 issue of NEJM Catalyst Innovations in Care Delivery.
Study Methodology
A prospective FWA study was conducted to evaluate the potential for using AI-driven technology to reduce FWA, improve affordability, enhance safety, and ensure equitable access to healthcare for socially vulnerable individuals. Researchers analyzed more than 2.6 million professional and institutional claims from over 276,000 members of employer-sponsored health plans received by the largest third-party administrator in the U.S. (now Personify Health, formerly HealthComp) between July 1, 2022 through March 31, 2023. Health at Scale's commercially available real-time AI-based technology was then applied to look for FWA in claims above a dollar threshold of $4,000 in the pre-payment period.
By incorporating the context of members' medical histories including acute and chronic health diagnoses, procedures, prescriptions and orders, and other related care encounters including providers seen, facilities, and care settings, the AI-based system was able to flag irregularities in claims with a high degree of accuracy, and with special attention to high-dollar anomalies. Flagged claims were then characterized by dollar amounts, service types, and member sub-groups determined by social determinants of health parameters.
About Health at Scale
Health at Scale uses advanced AI to drive smart, hyper-personalized, context-aware care delivery and management. Founded by machine learning and clinical faculty from MIT, Harvard, Stanford and the University of Michigan, the company brings precision to healthcare across a broad range of use cases, including: waste, abuse and fraud prevention, reduction of medical and drug errors, provider navigation and network curation, and early targeted prediction and prevention of adverse outcomes. For more information, please visit healthatscale.com.
About Personify Health
Virgin Pulse and HealthComp have merged to become Personify Health, the company driven to engage and empower people to live healthier lives. By bringing industry-leading health plan administration, holistic wellbeing, and navigation solutions together, all in one place, we have created the industry's first and only personalized health platform. With decades of experience and global operations, we empower diverse and unique businesses – and diverse and unique people – to engage more deeply in health at a lower cost. Through our proprietary combination of data-driven personalization, science-backed methodology, and concierge-level clinical expertise, our end-to-end platform makes it easier to proactively address people's needs across their lives. With a personalized, holistic, and powerfully simple experience, we are redefining industry expectations and what it means to manage health. Learn more at www.personifyhealth.com.
SOURCE Personify Health
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article